🧬 Omics-Insights: Your Weekly Genomics & Proteomics Digest 🧬

Welcome to our latest Omics newsletter, your portal for the freshest updates and innovations in genomics. This week's newsletter brings you the latest updates from the dynamic world of Omics. In this edition, we bring you the latest developments in the dynamic world of Omics, including key industry news, strategic collaborations, skill development essentials for finding a new job, & essential career tips for omics professionals.

This week's latest news in the field of Life Science:

🧬 Vevo Therapeutics and Parse Biosciences Create Record-Breaking Single Cell Atlas

Vevo Therapeutics, in partnership with Parse Biosciences, has unveiled Tahoe-100, the largest single-cell dataset ever created, comprising 100 million cells. Achieved in just one month through Parse’s GigaLab platform, this groundbreaking resource includes data from 60,000 conditions and 1,200 drug treatments across 50 tumor models. The dataset aims to accelerate AI-powered drug discovery and refine Vevo’s Mosaic platform. Parse's Evercode™ technology enables researchers to generate massive datasets with unprecedented speed and scale, powered by the UG 100™ sequencing platform in collaboration with Ultima Genomics. This partnership showcases the power of innovation in advancing drug development. #singlecell #drugdiscovery #biotech 🚀

🧪 OGT’s Enhanced Panel Advances Chronic Lymphocytic Leukemia Research

Oxford Gene Technology (OGT) has launched its SureSeq CLL + CNV V3 Panel, designed to enhance genetic profiling for chronic lymphocytic leukemia (CLL). Featuring improved bait designs and CNV detection, this panel delivers higher accuracy in identifying key biomarkers. With an impressive 100% detection rate for TP53 SNVs at low VAFs and 99% concordance with FISH testing, the panel addresses the needs of busy labs. Users praise its integration with OGT's Interpret software for simplified and efficient data analysis. This innovation equips researchers with tools to classify diseases and understand CLL progression confidently. #genomics #CLLresearch #precisionmedicine 💡

🔬 Quantum-Si Unveils Platinum® Kit for Protein Sequencing Breakthroughs

Quantum-Si has introduced the Platinum Library Prep Kit, V2, a game-changer in single-molecule protein sequencing. Designed for accessibility, this kit cuts hands-on prep time to under two hours and reduces protein input by fivefold, making it ideal for limited samples. With a success rate of 85% in generating libraries for sequencing, researchers gain deeper insights into the proteome. CEO Jeff Hawkins highlights its transformative potential, enabling labs to explore molecular complexity with ease. This advancement marks a step forward in next-gen protein sequencing. #proteomics #nextgensequencing #biotechinnovation 🎯

🌟 Ionpath’s MIBIscope™ 3.0: Redefining Spatial Proteomics Imaging

Ionpath has launched the MIBIscope™ 3.0, revolutionizing spatial proteomics with subcellular resolution and adjustable scanning capabilities. Researchers can now map intricate cellular interactions in tissues with over 40 biomarkers on a single slide. Features like walkaway mode and customizable settings ensure effortless, continuous imaging. CEO Paul Davy underscores its significance in advancing spatial biology, allowing labs to operate with precision and efficiency. This tool empowers discoveries that push scientific boundaries. #spatialbiology #proteomics #scientificinnovation 🖼️

💼 Abselion Secures £6.6M to Launch Amperia Protein Analyzer

Abselion has raised £6.6 million in Series A funding, led by M Ventures, to commercialize its Amperia system, a revolutionary at-line protein analyzer. Built on proprietary RED technology, Amperia quantifies antibodies and viral vectors directly from crude samples in under a minute. This innovation boosts efficiency in bioprocessing and life science research. CEO Ruizhi Wang emphasizes the system's real-time data capabilities, enabling confident decision-making. With support from investors like BioProcess 360 Partners, Abselion is set to transform protein quantification. #proteinanalysis #bioprocessing #biotechfunding 💸

Current Live Roles at Kinetica:

VP of Sales - Bioprocess - UK

Senior Account Manager - NGS Reagents - LA

Business Development Manager - NGS - DACH

Business Development Manager - Proteomics - Nordics

Sales Manager - Genomics Reagents - UK

Sales Director - Genomic Data Analysis - US

Senior Marketing Manager - Life Science - Cambridge

Job Hunting Tips from an Omics Specialist Recruiter: Quality Over Quantity in LinkedIn Connections

LinkedIn is a powerful tool for job seekers, especially in the competitive life sciences and genomics sectors. However, building a meaningful network isn't about having the largest number of connections—it’s about the right connections. Here’s why being selective with your LinkedIn network matters:

1. Relevance Matters: Accepting random requests or sending invites to just anyone dilutes the value of your network. Instead, focus on connecting with people who align with your professional goals—recruiters in your field, industry experts, and colleagues in related roles. A targeted network ensures that your feed and interactions remain relevant to your career aspirations. #networkingstrategy #jobhuntingtips #lifesciences
2. Credibility Counts: A carefully curated network reflects professionalism. When recruiters or potential employers look at your profile, they often browse your connections. A high-quality network shows you’re intentional and strategic, traits that employers value. #professionalism #careeradvice #genomics
3. Engagement Over Numbers: With a smaller, well-curated network, you’ll have more meaningful interactions. You’re more likely to see content that matters, participate in relevant discussions, and build authentic relationships. This engagement is far more valuable than being lost in a sea of connections. #engagement #connectionsmatter #lifesciencenetwork
4. Avoid Spam and Scams: Accepting unknown connections increases the risk of spam or even scams. Some profiles may seem legitimate but could lead to phishing attempts or misuse of your data. Protecting your professional identity is critical. #onlinesafety #linkedinsecurity #careersmart
5. The Recruiter’s Perspective: As a recruiter specializing in omics, I often prioritize candidates who have networks reflecting their professional interests. Seeing mutual connections with respected professionals in the industry or meaningful engagement on relevant posts adds weight to your profile during hiring evaluations. #recruitmenttips #omicscareers #linkedinprofile

When it comes to LinkedIn, think of your connections as a garden. Curate and nurture them thoughtfully—you’ll grow a network that truly supports your career goals. Remember, it’s not about collecting people; it’s about cultivating relationships. 🌱

Wrapping Up Another Omics-Insights:

Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as science!

#singlecell #drugdiscovery #biotech #genomics #precisionmedicine #aiindrugdiscovery #tumormodels #spatialbiology #proteomics #nextgensequencing #bioinformatics #lifescienceresearch #cancertreatment #highthroughput #molecularbiology #scientificbreakthroughs #pharmatechnology #datadrivendiscovery #genomicsequencing #cellbiology